Safety and Efficacy of Canagliflozin in Advanced CKD
Conditions: ESRD; CKD Stage 4; CKD Stage 5 Intervention: Drug: Invokana 300 mg and 100 mg tablet Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials